NEW YORK, NY / ACCESSWIRE / March 28, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.
RDI has Initiated Coverage Today on:
RNC Minerals
https://rdinvesting.com/news/?ticker=RNX.TO
Delivra Corp.
https://rdinvesting.com/news/?ticker=DVA.V
The Hydropothecary Corp.
https://rdinvesting.com/news/?ticker=THCX.V
VentriPoint Diagnostics Ltd.
https://rdinvesting.com/news/?ticker=VPT.V
RNC Minerals' stock moved 7.41% lower Tuesday, to close the day at $0.25. The stock recorded a trading volume of 1,183,513 shares, which was below its three months average volume of 1,851,043 shares. In the last year, RNC Minerals’ shares have traded in a range of 0.16 - 0.38. The share price has gained 56.25% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.26 is greater than its 200-day moving average of $0.21. Shares of RNC Minerals have gained approximately 38.89 percent year-to-date.
Access RDI’s RNC Minerals Research Report at:
https://rdinvesting.com/news/?ticker=RNX.TO
On Tuesday, shares of Delivra recorded a trading volume of 9,553 shares, which was below the three months average volume of 87,886 shares. The stock ended the day 5.71% lower at 0.33. The stock is currently trading 44.07% below its 52-week high with a 52-week trading range of 0.33 - 0.59. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.39 is below its 200-day moving average of $0.42. Shares of Delivra have fallen approximately 26.67 percent year-to-date.
Access RDI’s Delivra Corp. Research Report at:
https://rdinvesting.com/news/?ticker=DVA.V
The Hydropothecary 's stock moved 6.57% lower Tuesday, to close the day at $3.98. The stock recorded a trading volume of 1,984,718 shares, which was below its three months average volume of 2,825,833 shares. In the last year, The Hydropothecary 's shares have traded in a range of 1.10 - 13.80. The share price has gained 261.82% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $3.93 is greater than its 200-day moving average of $3.17. Shares of The Hydropothecary have fallen approximately 2.69 percent year-to-date.
Access RDI’s The Hydropothecary Corp. Research Report at:
https://rdinvesting.com/news/?ticker=THCX.V
On Tuesday, shares of VentriPoint Diagnostics recorded a trading volume of 35,000 shares, which was below the three months average volume of 298,148 shares. The stock ended the day flat at 0.30. The share price has gained 76.47% from its 52-week low with a 52-week trading range of 0.17 - 0.55. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.32 is greater than its 200-day moving average of $0.27. Shares of VentriPoint Diagnostics have fallen approximately 3.23 percent year-to-date.
Access RDI’s VentriPoint Diagnostics Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=VPT.V
Our Actionable Research on RNC Minerals (TSX:RNX.TO), Delivra Corp. (TSXV:DVA.V), The Hydropothecary Corp. (TSXV:THCX.V) and VentriPoint Diagnostics Ltd. (TSXV:VPT.V) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
contact@rdinvesting.com
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com